Efficacy of Vitex Agnus-castus BNO 1095 (20 mg) in Women With Primary Dysmenorrhea
Condition(s):Primary DysmenorrheaLast Updated:March 26, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Primary DysmenorrheaLast Updated:March 26, 2024Recruiting
Condition(s):Low Back PainLast Updated:April 19, 2022Completed
Condition(s):Fibrocystic Breast DiseaseLast Updated:February 8, 2023Completed
Condition(s):Premenstrual SyndromeLast Updated:October 1, 2009Completed
Condition(s):Mammographic Breast DensityLast Updated:August 4, 2020Unknown status
Condition(s):MenopauseLast Updated:November 21, 2012Unknown status
Condition(s):PMS; Menstrual Discomfort; Hormone Disturbance; Menstrual Pain; Menstrual IrregularityLast Updated:August 26, 2022Not yet recruiting
Condition(s):Premenstrual Syndrome; MastodyniaLast Updated:September 14, 2016Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.